Hereditary Thrombotic Thrombocytopenic Purpura in a Chinese Boy With a Novel Compound Heterozygous Mutation of the ADAMTS13 Gene

被引:5
|
作者
Dai, Yi-ling [1 ,2 ]
Tang, Xue [1 ,2 ]
Chen, Hong-bo [1 ,2 ]
Peng, Qiu-yu [1 ,2 ]
Guo, Xia [1 ,2 ]
Gao, Ju [1 ,2 ]
机构
[1] Sichuan Univ, West China Univ Hosp 2, Dept Pediat, Chengdu, Sichuan, Peoples R China
[2] Sichuan Univ, Key Lab Birth Defects & Related Dis Women & Child, Minist Educ, Chengdu, Sichuan, Peoples R China
来源
FRONTIERS IN PEDIATRICS | 2020年 / 8卷
基金
中国国家自然科学基金;
关键词
hereditary thrombotic thrombocytopenic purpura; Upshaw-Schulman syndrome; ADAMTS13; novel mutation; Chinese; UPSHAW-SCHULMAN SYNDROME; DEFICIENCY; TTP;
D O I
10.3389/fped.2020.00554
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Hereditary thrombotic thrombocytopenic purpura (TTP) is caused byADAMTS13mutations with autosomal recessive inheritance. It typically presents during childhood and is frequently misdiagnosed as immune thrombocytopenia. We present a case of hereditary TTP with an undescribed compound heterozygousADAMTS13mutation in a Chinese boy. A 12-year-old boy with a history of intermittent thrombocytopenia in the prior 6 years had severe deficiency of plasma ADAMTS13 and harbored a novel compound heterozygous mutation which was also identified in his sister. The c.577C>T was a pathogenic variant reported exclusively in Japanese cases. The undescribed c.2397C>A non-sense mutation was predicted to encode a truncated protein. Identification of the specific novel heterozygousADAMTS13mutation in the Chinese family, consisting a variant restricted to Asian individuals and an undescribed c.2397C>A non-sense mutation, demonstrates genetic diversity underlying hereditary TTP, and possibly ethnic skewed mutation profiles.
引用
收藏
页数:5
相关论文
共 50 条
  • [41] VALIDATION OF A NOVEL ADAMTS13 ASSAY FOR CHARACTERIZATION OF PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA
    Barton, J. Cameron
    Miranda, Frida
    Anderson, Cooper
    Muia, Joshua
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 : E9 - E10
  • [42] Proteolysis of ADAMTS13 in acute phase thrombotic thrombocytopenic purpura
    Feys, H. B.
    Vandeputte, N.
    Peerlinck, K.
    Peyvandi, F.
    Vanhoorelbeke, K.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 655 - 655
  • [43] ADAMTS13 and von Willebrand Factor in Thrombotic Thrombocytopenic Purpura
    Zheng, X. Long
    ANNUAL REVIEW OF MEDICINE, VOL 66, 2015, 66 : 211 - 225
  • [44] Pathogenesis of thrombotic thrombocytopenic purpura: ADAMTS13 deficiency and beyond
    Lian, ECY
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2005, 31 (06): : 625 - 632
  • [45] Congenital thrombotic thrombocytopenic purpura in association with a mutation in the second CUB domain of ADAMTS13
    Pimanda, JE
    Maekawa, A
    Wind, T
    Paxton, J
    Chesterman, CN
    Hogg, PJ
    BLOOD, 2004, 103 (02) : 627 - 629
  • [46] Diagnosis of Thrombotic Thrombocytopenic Purpura by ADAMTS13 Activity Quantification
    Dimopoulos, Konstantinos
    Philips, Malou
    Goetze, Jens P.
    JOURNAL OF APPLIED LABORATORY MEDICINE, 2022, 7 (03): : 637 - 649
  • [47] Utility of ADAMTS13 Assays in Diagnosing Thrombotic Thrombocytopenic Purpura
    Lehman, Christopher M.
    Rodgers, George M.
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2015, 139 (04) : 433 - 433
  • [48] Molecular basis of ADAMTS13 dysfunction in thrombotic thrombocytopenic purpura
    Minola Manea
    Diana Karpman
    Pediatric Nephrology, 2009, 24 : 447 - 458
  • [49] Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura
    Sadler, J. Evan
    BLOOD, 2008, 112 (01) : 11 - 18
  • [50] ADAMTS13 Biomarkers in Management of Immune Thrombotic Thrombocytopenic Purpura
    Sui, Jingrui
    Zheng, Liang
    Zheng, X. Long
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2023, 147 (08) : 974 - 979